The promise of retinoids to fight against cancer
- PMID:11902573
- DOI: 10.1038/35106036
The promise of retinoids to fight against cancer
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Similar articles
- Retinoids as chemopreventive agents.Ralhan R, Kaur J.Ralhan R, et al.J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):66-91.J Biol Regul Homeost Agents. 2003.PMID:12757022Review.
- Retinoids in chemoprevention and differentiation therapy.Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM.Hansen LA, et al.Carcinogenesis. 2000 Jul;21(7):1271-9.Carcinogenesis. 2000.PMID:10874003Review.
- Retinoids and TRAIL: two cooperating actors to fight against cancer.Altucci L, Gronemeyer H.Altucci L, et al.Vitam Horm. 2004;67:319-45. doi: 10.1016/S0083-6729(04)67017-8.Vitam Horm. 2004.PMID:15110184Review.
- Retinoids: potential in cancer prevention and therapy.Clarke N, Germain P, Altucci L, Gronemeyer H.Clarke N, et al.Expert Rev Mol Med. 2004 Nov 30;6(25):1-23. doi: 10.1017/S1462399404008488.Expert Rev Mol Med. 2004.PMID:15569396Review.
- Retinoic acid signaling in myelopoiesis.Drumea K, Yang ZF, Rosmarin A.Drumea K, et al.Curr Opin Hematol. 2008 Jan;15(1):37-41. doi: 10.1097/MOH.0b013e3282f20a9c.Curr Opin Hematol. 2008.PMID:18043244Review.
Cited by
- Epigenetic therapies in MDS and AML.Griffiths EA, Gore SD.Griffiths EA, et al.Adv Exp Med Biol. 2013;754:253-83. doi: 10.1007/978-1-4419-9967-2_13.Adv Exp Med Biol. 2013.PMID:22956506Free PMC article.Review.
- Retinoids for preventing the progression of cervical intra-epithelial neoplasia.Helm CW, Lorenz DJ, Meyer NJ, Rising WW, Wulff JL.Helm CW, et al.Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD003296. doi: 10.1002/14651858.CD003296.pub3.Cochrane Database Syst Rev. 2013.PMID:23740788Free PMC article.Review.
- Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies.Koushik A, Wang M, Anderson KE, van den Brandt P, Clendenen TV, Eliassen AH, Freudenheim JL, Genkinger JM, Håkansson N, Marshall JR, McCullough ML, Miller AB, Robien K, Rohan TE, Schairer C, Schouten LJ, Tworoger SS, Wang Y, Wolk A, Zeleniuch-Jacquotte A, Smith-Warner SA.Koushik A, et al.Cancer Causes Control. 2015 Sep;26(9):1315-27. doi: 10.1007/s10552-015-0626-0. Epub 2015 Jul 14.Cancer Causes Control. 2015.PMID:26169298Free PMC article.
- ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells.Hirota A, Clément JE, Tanikawa S, Nonoyama T, Komatsuzaki T, Gong JP, Tanaka S, Imajo M.Hirota A, et al.Cancers (Basel). 2022 Nov 29;14(23):5890. doi: 10.3390/cancers14235890.Cancers (Basel). 2022.PMID:36497371Free PMC article.
- Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.Zolfaghari R, Cifelli CJ, Lieu SO, Chen Q, Li NQ, Ross AC.Zolfaghari R, et al.Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1029-36. doi: 10.1152/ajpgi.00494.2006. Epub 2006 Dec 21.Am J Physiol Gastrointest Liver Physiol. 2007.PMID:17185629Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources